Oklo公司最近与人工智能解决方案提供商和数据中心运营商Switch达成协议，未来将为其提供高达12千兆瓦的能源支持。这一发展不仅为Oklo的商业前景打下基础，也让人对其能否在核能市场中占据一席之地充满期待。

智通财经APP获悉，英伟达(NVDA.US)首席执行官黄仁勋将于周一在2025年美国消费电子展(CES)上发表开幕主题演讲。投行Wedbush表示，黄仁勋的演讲可能会聚焦于这家人工智能芯片巨头对人工智能的愿景上。Wedbush分析师Dan ...

另一方面，Salesforce作为全球领先的客户关系管理（CRM）软件公司，也在积极推进AI战略。近期，Salesforce推出了以“Einstein ...

英伟达 (NVDA.US)首席执行官黄仁勋将于周一在2025年美国消费电子展 (CES)上发表开幕主题演讲。投行Wedbush表示，黄仁勋的演讲可能会聚焦于这家人工智能芯片巨头对人工智能的愿景上。

Wedbush downgraded Keros Therapeutics (KROS) to Neutral from Outperform with a price target of $15, down from $47. The firm has removed cibotercept for pulmonary arterial hypertension from the ...

英为财情Investing.com - Wedbush分析师Daniel Ives领导的团队预计，在特朗普当选的情况下，监管压力减轻将推动科技股在2025年上涨25%。联邦贸易委员会（FTC）主席 Lina Khan离职以及华盛顿对人工智能（AI）更加友好的环境，也是大型科技公司明年的利好因素。

Wedbush Securities周四开始追踪Oklo—— OpenAI负责人Sam Altman支持的核电初创公司 —— 并给予其“跑赢大盘”的评级。而前一天，该公司宣布与人工智能 ...

Wedbush currently has a “Neutral” rating and a $29.00 price target on the stock. The consensus estimate for NovoCure’s current full-year earnings is ($1.32) per share.

KB Home (NYSE:KBH – Free Report) – Investment analysts at Wedbush reduced their FY2025 earnings per share estimates for shares of KB Home in a note issued to investors on Monday, January 13th.

Dan Ives, Wedbush Securities global head of tech research, joins CNBC's 'The Exchange' to discuss the looming TikTok ban in ...

In a report released today, Jay McCanless from Wedbush reiterated a Hold rating on DR Horton (DHI – Research Report), with a price target of $180.00. The company’s shares closed yesterday at ...

The popular platform could be banned on Jan. 19 under a federal law, while many parties have expressed interest in buying the ...